Choleretic effect of inchinkoto, a herbal medicine, on livers of patients with biliary obstruction due to bile duct carcinoma

Hepatology Research

Volumn 39, Issue 3, 2009, Pages 247-255

  Watanabe, Shinya ^a   Yokoyama, Yukihiro ^a   Oda, Koji ^a   Kokuryo, Toshio ^a   Shoda, Junichi ^b   Okada, Kosuke ^b   Utsunomiya, Hirotoshi ^c   Nagino, Masato ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Biliary obstruction; Hepatic failure; Japanese herbal medicine; MRP2

Indexed keywords

BILE ACID; BILIRUBIN; INCHINKO TO; MULTIDRUG RESISTANCE PROTEIN 2; MULTIDRUG RESISTANCE PROTEIN 3; MULTIDRUG RESISTANCE PROTEIN 4;

ARTICLE; ARTIFICIAL EMBOLISM; BILE ACID BLOOD LEVEL; BILE DUCT CARCINOMA; BILE DUCT OBSTRUCTION; BILIARY TRACT DRAINAGE; BILIRUBIN BLOOD LEVEL; CELL MEMBRANE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; INTRAHEPATIC BILE DUCT; LIVER RESECTION; POSTOPERATIVE COMPLICATION; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL;

EID: 69249212587     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2008.00453.x     Document Type: Article

References (29)

1. Kamiya S, Nagino M, Kanazawa H et al. The value of bile replacement during external biliary drainage: An analysis of intestinal permeability, integrity, and microflora. Ann Surg 2004; 239: 510-17.
2. Dixon JM, Armstrong CP, Duffy SW, Davies GC. Factors affecting morbidity and mortality after surgery for obstructive jaundice: A review of 373 patients. Gut 1983; 24: 845-52.
3. Jiang WG, Puntis MC. Immune dysfunction in patients with obstructive jaundice, mediators and implications for treatments. HPB Surg 1997; 10: 129-42.
4. Arai T, Yoshikai Y, Kamiya J et al. Bilirubin impairs bactericidal activity of neutrophils through an antioxidant mechanism in vitro. J Surg Res 2001; 96: 107-13.
5. Trauner M, Meier PJ, Boyer JL. Molecular pathogenesis of cholestasis. N Engl J Med 1998; 339: 1217-27.
6. Trauner M, Arrese M, Soroka CJ et al. The rat canalicular conjugate export pump (Mrp2) is down-regulated in intrahepatic and obstructive cholestasis. Gastroenterology 1997; 113: 255-64.
7. Yamada T, Arai T, Nagino M et al. Impaired expression of hepatic multidrug resistance protein 2 is associated with posthepatectomy hyperbilirubinemia in patients with biliary cancer. Langenbecks Arch Surg 2005; 390: 421-9.
8. Yokooji T, Murakami T, Yumoto R, Nagai J, Takano M. Function of multidrug resistance-associated protein 2 in acute hepatic failure rats. Eur J Pharmacol 2006; 546: 152-60.
9. Fickert P, Zollner G, Fuchsbichler A et al. Effects of ursodeoxycholic and cholic acid feeding on hepatocellular transporter expression in mouse liver. Gastroenterology 2001; 121: 170-83.
10. Wagner M, Fickert P, Zollner G et al. Role of farnesoid X receptor in determining hepatic ABC transporter expression and liver injury in bile duct-ligated mice. Gastroenterology 2003; 125: 825-38.
11. Yamamoto M, Miura N, Ohtake N et al. Genipin, a metabolite derived from the herbal medicine Inchin-ko-to, and suppression of Fas-induced lethal liver apoptosis in mice. Gastroenterology 2000; 118: 380-9.
12. Yamamoto M, Ogawa K, Morita M, Fukuda K, Komatsu Y. The herbal medicine Inchin-ko-to inhibits liver cell apoptosis induced by transforming growth factor beta 1. Hepatology 1996; 23: 552-9.
13. Kobayashi H, Horikoshi K, Yamataka A, Lane GJ, Yamamoto M, Miyano T. Beneficial effect of a traditional herbal medicine (inchin-ko-to) in postoperative biliary atresia patients. Pediatr Surg Int 2001; 17: 386-9.
14. Shoda J, Miura T, Utsunomiya H et al. Genipin enhances Mrp2 (Abcc2)-mediated bile formation and organic anion transport in rat liver. Hepatology 2004; 39: 167-78.
15. Okada K, Shoda J, Kano M et al. Inchinkoto, a herbal medicine, and its ingredients dually exert Mrp2/MRP2-mediated choleresis and Nrf2-mediated antioxidative action in rat livers. Am J Physiol Gastrointest Liver Physiol 2007; 292: G1450-63.
16. Shoda J, Inada Y, Tsuji A et al. Bezafibrate stimulates canalicular localization of NBD-labeled PC in HepG2 cells by PPARalpha-mediated redistribution of ABCB4. J Lipid Res 2004; 45: 1813-25.
17. Cao J, Stieger B, Meier PJ, Vore M. Expression of rat hepatic multidrug resistance-associated proteins and organic anion transporters in pregnancy. Am J Physiol Gastrointest Liver Physiol 2002; 283: G757-66.
18. Ogawa K, Suzuki H, Hirohashi T et al. Characterization of inducible nature of MRP3 in rat liver. Am J Physiol Gastrointest Liver Physiol 2000; 278: G438-46.
19. Shoda J, Kano M, Oda K et al. The expression levels of plasma membrane transporters in the cholestatic liver of patients undergoing biliary drainage and their association with the impairment of biliary secretory function. Am J Gastroenterol 2001; 96: 3368-78.
20. Abe T, Arai T, Ogawa A et al. Kupffer cell-derived interleukin 10 is responsible for impaired bacterial clearance in bile duct-ligated mice. Hepatology 2004; 40: 414-23.
21. Suzuki H, Iyomasa S, Nimura Y, Yoshida S. Internal biliary drainage, unlike external drainage, does not suppress the regeneration of cholestatic rat liver after partial hepatectomy. Hepatology 1994; 20: 1318-22.
22. Iyomasa S, Terasaki M, Kuriki H et al. Decrease in regeneration capacity of rat liver after external biliary drainage. Eur Surg Res 1992; 24: 265-72.
23. Cherqui D, Benoist S, Malassagne B, Humeres R, Rodriguez V, Fagniez PL. Major liver resection for carcinoma in jaundiced patients without preoperative biliary drainage. Arch Surg 2000; 135: 302-8.
24. Higuchi R, Otsubo T, Takasaki K. Evaluation of functional liver reserve in patients with obstructive jaundice undergoing hepatectomy. Hepatogastroenterology 2005; 52: 537-40.
25. Kullak-Ublick GA, Beuers U, Paumgartner G. Hepatobiliary transport. J Hepatol 2000; 32: 3-18.
26. Zollner G, Fickert P, Zenz R et al. Hepatobiliary transporter expression in percutaneous liver biopsies of patients with cholestatic liver diseases. Hepatology 2001; 33: 633-46.
27. Tanaka Y, Kobayashi Y, Gabazza EC et al. Increased renal expression of bilirubin glucuronide transporters in a rat model of obstructive jaundice. Am J Physiol Gastrointest Liver Physiol 2002; 282: G656-62.
28. Bohan A, Chen WS, Denson LA, Held MA, Boyer JL. Tumor necrosis factor alpha-dependent up-regulation of Lrh-1 and Mrp3(Abcc3) reduces liver injury in obstructive cholestasis. J Biol Chem 2003; 278: 36688-98.
29. Tamura T, Kobayashi H, Yamataka A, Lane GJ, Koga H, Miyano T. Inchin-ko-to prevents medium-term liver fibrosis in postoperative biliary atresia patients. Pediatr Surg Int 2007; 23: 343-7.